Efficacy and safety of Glucosamine sulfate and chondroitin sulfate combination in the treatment of haemophilic arthropathy: randomized, double-blind, placebo-controlled trial
- Conditions
- Orthopaedics
- Registration Number
- PACTR202002466895205
- Lead Sponsor
- Faculty of pharmacy university of khartoum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 45
•patients diagnosed as having haemophilia A or B,
•patients at least 5 years old at the time of enrollment,
•patients classified as having haemophilc arthropathy in Arnold-Hilgartner scale,
•no concurrent medical or arthritic conditions that could confound evaluation of the index joint,
•No other active or severe diseases.
•Patients with bleeding disorders other than haemophilia A and B,
•Patients less than 5 years old,
•Patients with severe haemophilic arthropathy classified as class O, or IV in Arnold-Hilgartner scale of haemophilic arthropathy,
•Patients with positive results in HIV, HB, or HC screening tests.
•a history of clinically significant trauma or surgery to the joints,
•Or coexisting disease that could preclude successful completion of the trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method